PACS software drives ISG's growth

Article

ISG Technologies continues to move forward from its proxy fight of a year ago. The Mississauga, Ontario-based medical imaging software developer reported an 8% increase in revenue for its 1998 fiscal first quarter, bringing sales to a company record for

ISG Technologies continues to move forward from its proxy fight of a year ago. The Mississauga, Ontario-based medical imaging software developer reported an 8% increase in revenue for its 1998 fiscal first quarter, bringing sales to a company record for the period.

ISG reported revenues of $5.8 million (U.S.) for the period (end-September), compared with $5.4 million in the first quarter of 1997. Net income was $6400, compared with a net loss of $780,000 in the same period last year. No extraordinary charges were reported during the quarter. The company increased its backlog during the period by more than $6.3 million, representing multiyear agreements for licensed software and contract engineering work, according to the firm.

While revenues from the company's image-guided surgery line were down significantly, substantial gains in sales of ISG's Viewing and Reading Station (VRS) PACS software offset the loss, resulting in overall flat revenues of $2.8 million for the company's licensed software efforts. Contract R&D revenues rose 48% to $2.8 million.

The company also reported favorable developments in its IAP medical imaging console software business. In other quarterly developments, ISG released a Windows NT version of its VRS product line. Previously, VRS was based exclusively on the Unix operating system.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.